Frequently bought together:
Description
BRAF inhibitor | HY-10247
BRAF inhibitor is a B-Raf inhibitor extracted from patent WO/2011103196 A1, Compound P-0850.
IC50 & Target :
B-Raf
Molecular weight:
456.47
Formula:
C22H18F2N4O3S
SMILES:
CC(C)S(=O)(NC1=CC=C(C(C(C2=CNC3=NC=C(C=C32)C4=CC=CN=C4)=O)=C1F)F)=O
Storage:
Related Products
AKT Kinase Inhibitor | HY-10249A
Gentaur
AKT Kinase Inhibitor | HY-10249A
AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1].
IC50 & Target :
Akt
In Vitro:
The effect of selective inhibition of Akt in...
RIBOAssure RNase Inhibitor | RI001-0125
Gentaur
RIBOAssure RNase Inhibitor | RI001-0125
As a recombinant human placental protein expressed in Escherichia coli, the RIBOAssu
Basimglurant | HY-15446
Gentaur
Basimglurant | HY-15446
Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1].
IC50 & Target :
Navitoclax | HY-10087
Gentaur
Navitoclax | HY-10087
Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2...
Adezmapimod hydrochloride | HY-10256A
Gentaur
Adezmapimod hydrochloride | HY-10256A
Adezmapimod (SB 203580) hydrochloride is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2,...